CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre
Australasian Journal of Dermatology · 2023
DOI: 10.1111/ajd.14016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Australasian Journal of Dermatology, 2023. Verfasst von Friyana K Bhabha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lymphomatoid Papulosis, Lymphoproliferative Disorders, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
The CD30‐postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of all cutaneous T‐cell lymphomas (CTCLs) and are the second most common form of CTCLs after mycosis fungoides. Both conditions differ in their clinical presentations; however, they share the expression of the CD30 antigen as a common immunophenotypic hallmark. There is a wide spectrum of management options depending on factors such as extent of disease, staging and treatment tolerability. This Clinical Practice Statement is reflective of the current clinical practice in Australia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Nurse Practitioner, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
ORCID-Profile: Friyana K Bhabha
Zitieren
APA
Bhabha, F. K., McCormack, C., Campbell, B. A., Lade, S., Buelens, O., Van Der Weyden, C., & Prince, H. M. (2023). CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14016
Vancouver
Bhabha FK, McCormack C, Campbell BA, Lade S, Buelens O, Van Der Weyden C, et al. CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. 2023. doi:10.1111/ajd.14016
BibTeX
@article{Bhabha2023,
author = {Bhabha, Friyana K and McCormack, Christopher and Campbell, Belinda A and Lade, Stephen and Buelens, Odette and Van Der Weyden, Carrie and Prince, H Miles},
title = {CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre},
journal = {Australasian Journal of Dermatology},
year = {2023},
doi = {10.1111/ajd.14016}
}
EUVIMED